122 related articles for article (PubMed ID: 38160627)
1. Lung metastasis-Harnessed in-Situ adherent porous organic nanosponge-mediated antigen capture for A self-cascaded detained dendritic cells and T cell infiltration.
Wu TH; Lu YJ; Chiang MR; Chen PH; Lee YS; Shen MY; Chiang WH; Liu YC; Chuang CY; Amy Lin HC; Hu SH
Biomaterials; 2024 Mar; 305():122443. PubMed ID: 38160627
[TBL] [Abstract][Full Text] [Related]
2. Programmed T cells infiltration into lung metastases with harnessing dendritic cells in cancer immunotherapies by catalytic antigen-capture sponges.
Chiang MR; Shen WT; Huang PX; Wang KL; Weng WH; Chang CW; Chiang WH; Liu YC; Chang SJ; Hu SH
J Control Release; 2023 Aug; 360():260-273. PubMed ID: 37364798
[TBL] [Abstract][Full Text] [Related]
3. Programmed antigen capture-harnessed dendritic cells by margination-hitchhiking lung delivery.
Huynh TMH; Yalamandala BN; Chiang MR; Weng WH; Chang CW; Chiang WH; Liao LD; Liu YC; Hu SH
J Control Release; 2023 Jun; 358():718-728. PubMed ID: 37230295
[TBL] [Abstract][Full Text] [Related]
4. Antigen-Capturing Dendritic-Cell-Targeting Nanoparticles for Enhanced Tumor Immunotherapy Based on Photothermal-Therapy-Induced In Situ Vaccination.
Li Y; Luo Y; Hou L; Huang Z; Wang Y; Zhou S
Adv Healthc Mater; 2023 Sep; 12(22):e2202871. PubMed ID: 37276021
[TBL] [Abstract][Full Text] [Related]
5. Marginative Delivery-Mediated Extracellular Leakiness and T Cell Infiltration in Lung Metastasis by a Biomimetic Nanoraspberry.
Shen WT; Hsu RS; Fang JH; Hu PF; Chiang CS; Hu SH
Nano Lett; 2021 Feb; 21(3):1375-1383. PubMed ID: 33562964
[TBL] [Abstract][Full Text] [Related]
6. Induction of tumor-specific cytotoxic T lymphocytes in cancer patients by autologous tumor RNA-transfected dendritic cells.
Nair SK; Morse M; Boczkowski D; Cumming RI; Vasovic L; Gilboa E; Lyerly HK
Ann Surg; 2002 Apr; 235(4):540-9. PubMed ID: 11923611
[TBL] [Abstract][Full Text] [Related]
7. In vitro induction of tumor-specific human lymphocyte antigen class I-restricted CD8 cytotoxic T lymphocytes by ovarian tumor antigen-pulsed autologous dendritic cells from patients with advanced ovarian cancer.
Santin AD; Hermonat PL; Ravaggi A; Bellone S; Pecorelli S; Cannon MJ; Parham GP
Am J Obstet Gynecol; 2000 Sep; 183(3):601-9. PubMed ID: 10992180
[TBL] [Abstract][Full Text] [Related]
8. Intralymphatic dendritic cell vaccination induces tumor antigen-specific, skin-homing T lymphocytes.
Grover A; Kim GJ; Lizée G; Tschoi M; Wang G; Wunderlich JR; Rosenberg SA; Hwang ST; Hwu P
Clin Cancer Res; 2006 Oct; 12(19):5801-8. PubMed ID: 17020987
[TBL] [Abstract][Full Text] [Related]
9. Induction of antitumor cytotoxic lymphocytes using engineered human primary blood dendritic cells.
Wu L; Zhang H; Jiang Y; Gallo RC; Cheng H
Proc Natl Acad Sci U S A; 2018 May; 115(19):E4453-E4462. PubMed ID: 29674449
[TBL] [Abstract][Full Text] [Related]
10. Self-adjuvanting nanoemulsion targeting dendritic cell receptor Clec9A enables antigen-specific immunotherapy.
Zeng B; Middelberg AP; Gemiarto A; MacDonald K; Baxter AG; Talekar M; Moi D; Tullett KM; Caminschi I; Lahoud MH; Mazzieri R; Dolcetti R; Thomas R
J Clin Invest; 2018 May; 128(5):1971-1984. PubMed ID: 29485973
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal Stromal Stem Cell-Derived Microvesicles Enhance Tumor Lysate Pulsed Dendritic Cell Stimulated Autologous T lymphocyte Cytotoxicity.
Rahmani Kukia N; Alipanah-Moghadam R; Delirezh N; Mazani M
Asian Pac J Cancer Prev; 2018 Jul; 19(7):1895-1902. PubMed ID: 30049202
[TBL] [Abstract][Full Text] [Related]
12. A self-cascaded unimolecular prodrug for pH-responsive chemotherapy and tumor-detained photodynamic-immunotherapy of triple-negative breast cancer.
Yao D; Wang Y; Bian K; Zhang B; Wang D
Biomaterials; 2023 Jan; 292():121920. PubMed ID: 36442436
[TBL] [Abstract][Full Text] [Related]
13. Tumor cell lysates as immunogenic sources for cancer vaccine design.
González FE; Gleisner A; Falcón-Beas F; Osorio F; López MN; Salazar-Onfray F
Hum Vaccin Immunother; 2014; 10(11):3261-9. PubMed ID: 25625929
[TBL] [Abstract][Full Text] [Related]
14. Dendritic cell-based immunotherapy for colon cancer using an HLA-A*0201-restricted cytotoxic T-lymphocyte epitope from tumor-associated antigen 90K.
Hee Lee J; Park MS; Hwang JE; Cho SH; Bae WK; Shim HJ; Kim DE; Chung IJ
Cell Mol Immunol; 2013 May; 10(3):275-82. PubMed ID: 23524651
[TBL] [Abstract][Full Text] [Related]
15. Recent Advances in Lung Cancer Immunotherapy: Input of T-Cell Epitopes Associated With Impaired Peptide Processing.
Leclerc M; Mezquita L; Guillebot De Nerville G; Tihy I; Malenica I; Chouaib S; Mami-Chouaib F
Front Immunol; 2019; 10():1505. PubMed ID: 31333652
[TBL] [Abstract][Full Text] [Related]
16. Calreticulin acts as an adjuvant to promote dendritic cell maturation and enhances antigen-specific cytotoxic T lymphocyte responses against non-small cell lung cancer cells.
Liu X; Li J; Liu Y; Ding J; Tong Z; Liu Y; Zhou Y; Liu Y
Cell Immunol; 2016 Feb; 300():46-53. PubMed ID: 26702740
[TBL] [Abstract][Full Text] [Related]
17. Relationship of vaccine efficacy to the kinetics of DC and T-cell responses induced by PLG-based cancer vaccines.
Ali OA; Doherty E; Mooney DJ; Emerich D
Biomatter; 2011; 1(1):66-75. PubMed ID: 23507728
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of antitumor immunity by combining anti-cytotoxic T lymphocyte antigen-4 antibodies and cryotreated tumor lysate-pulsed dendritic cells in murine osteosarcoma.
Kawano M; Itonaga I; Iwasaki T; Tsumura H
Oncol Rep; 2013 Mar; 29(3):1001-6. PubMed ID: 23291864
[TBL] [Abstract][Full Text] [Related]
19. Nanoscale Metal-Organic Frameworks for Cancer Immunotherapy.
Ni K; Luo T; Nash GT; Lin W
Acc Chem Res; 2020 Sep; 53(9):1739-1748. PubMed ID: 32808760
[TBL] [Abstract][Full Text] [Related]
20. Dendritic Cell-Based Immunotherapy in Lung Cancer.
Stevens D; Ingels J; Van Lint S; Vandekerckhove B; Vermaelen K
Front Immunol; 2020; 11():620374. PubMed ID: 33679709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
